Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Compalati

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Allergy|May 21, 2019
Dose escalation using carbamylated monomeric tree pollen drops is well tolerated in patients with allergic rhinoconjunctivitis and points towards clinical effectsEsther Raskopf, Silke Allekotte, Enrico Compalati, et al.
Expert Review of Clinical Immunology|May 6, 2010
The link between allergic rhinitis and asthma: the united airways diseaseEnrico Compalati, Erminia Ridolo, Giovanni Passalacqua, et al.
Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)|February 19, 2004
Sublingual immunotherapyGiovanni Passalacqua, Laura Guerra Enrico Compalati, Mercedes Pasquali, et al.
Current Allergy and Asthma Reports|August 11, 2006
New insights in sublingual immunotherapyGiovanni Passalacqua, Laura Guerra, Enrico Compalati, et al.
The World Allergy Organization Journal|August 7, 2023
Update meta-analysis on the efficacy and safety issues of fexofenadineRené Maximiliano Gómez, Pablo Moreno, Enrico Compalati, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 24, 2013
Author responseDésirée Larenas Linnemann, Enrico Compalati, Michael Blaiss, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 28, 2013
Pediatric sublingual immunotherapy efficacy: evidence analysis, 2009-2012Désirée Larenas-Linnemann, Michael Blaiss, Hugo P Van Bever, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 30, 2006
Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trialsMartin Penagos, Enrico Compalati, Francesco Tarantini, et al.
Italian Journal of Pediatrics|November 15, 2011
DRACMA one year after: which changes have occurred in diagnosis and treatment of CMA in Italy?Alessandro Fiocchi, Holger Schunemann, Luigi Terracciano, et al.
Chest|October 24, 2007
Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of ageMartin Penagos, Giovanni Passalacqua, Enrico Compalati, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Allergy|May 21, 2019
Dose escalation using carbamylated monomeric tree pollen drops is well tolerated in patients with allergic rhinoconjunctivitis and points towards clinical effectsEsther Raskopf, Silke Allekotte, Enrico Compalati, et al.
Expert Review of Clinical Immunology|May 6, 2010
The link between allergic rhinitis and asthma: the united airways diseaseEnrico Compalati, Erminia Ridolo, Giovanni Passalacqua, et al.
Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)|February 19, 2004
Sublingual immunotherapyGiovanni Passalacqua, Laura Guerra Enrico Compalati, Mercedes Pasquali, et al.
Current Allergy and Asthma Reports|August 11, 2006
New insights in sublingual immunotherapyGiovanni Passalacqua, Laura Guerra, Enrico Compalati, et al.
The World Allergy Organization Journal|August 7, 2023
Update meta-analysis on the efficacy and safety issues of fexofenadineRené Maximiliano Gómez, Pablo Moreno, Enrico Compalati, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 24, 2013
Author responseDésirée Larenas Linnemann, Enrico Compalati, Michael Blaiss, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 28, 2013
Pediatric sublingual immunotherapy efficacy: evidence analysis, 2009-2012Désirée Larenas-Linnemann, Michael Blaiss, Hugo P Van Bever, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 30, 2006
Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trialsMartin Penagos, Enrico Compalati, Francesco Tarantini, et al.
Italian Journal of Pediatrics|November 15, 2011
DRACMA one year after: which changes have occurred in diagnosis and treatment of CMA in Italy?Alessandro Fiocchi, Holger Schunemann, Luigi Terracciano, et al.
Chest|October 24, 2007
Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of ageMartin Penagos, Giovanni Passalacqua, Enrico Compalati, et al.
Pageof 7